A biosimilar is designed to be highly similar to, and have “no clinically meaningful differences” from, its reference product. Learn more
As we commit to building a more sustainable healthcare system, biosimilars offer an affordable treatment option for patients. Learn more
Biosimilars development is complex, since biosimilarities can only be established through comparator clinical trials with the reference drug. Learn more
